Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
48.78
+0.79 (1.65%)
At close: Aug 4, 2026
Shanghai Rendu Biotechnology Company Description
Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of molecular diagnostic reagents products and supporting equipment in China and internationally.
Its products are used in various therapeutic areas, including reproductive tract, respiratory tract, enterovirus infections, and bloodborne infectious diseases, as well as tumor auxiliary diagnosis.
The company was founded in 2007 and is based in Shanghai, China.
Shanghai Rendu Biotechnology Co., Ltd.
| Country | China |
| Founded | 2007 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 239 |
| CEO | Minghui Yu |
Contact Details
Address: Building 15 Shanghai, 201201 China | |
| Phone | 86 21 5072 0200 |
| Website | rdbio.com |
Stock Details
| Ticker Symbol | 688193 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000059K5 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Jinliang Ju | Chairman of the Board and Chief Scientist |
| Minghui Yu | GM and Director |
| Tingjiang Cai | Accounting Officer, Accounting Supervisor, Chief Financial Officer and Secretary |
| Ruohua Cao | Deputy GM and Director |
| Zhenling Cui | Senior Director of Research & Development |
| Hao Jin | Deputy Director of Instrumentation |
| Chang E Zhang | Registration Director and Director of Manufacturing Center |